Canada – Special Access Program for drugs: Guidance document for industry and practitioners

This guidance document explains the regulatory information requirements and conditions for practitioners and manufacturers when drugs are requested through the Special Access Program (SAP). It explains SAP’s mandate, intent and scope, and outlines the responsibilities of practitioners and manufacturers…